Xinpei Y. Deng

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Antibody-drug conjugate-related marker heterogeneity between primary tumors and metastatic lymph nodes in advanced urothelial cancers.

Antibody-drug conjugate-related marker heterogeneity between primary tumors and metastatic lymph nodes in advanced urothelial cancers.

Journal: Journal of translational internal medicine

Published: July 02, 2026

The Expression Patterns of Antibody-Drug Conjugate-Related Markers in Urothelial Carcinoma With Histological Variants.

The Expression Patterns of Antibody-Drug Conjugate-Related Markers in Urothelial Carcinoma With Histological Variants.

Journal: MedComm

Published: February 18, 2026

Diagnostic performance analysis of two-gene methylation in urothelial carcinoma based on small-volume urine sample.

Diagnostic performance analysis of two-gene methylation in urothelial carcinoma based on small-volume urine sample.

Journal: Cancer

Published: November 12, 2025

Neutrophil extracellular traps-STC1 positive feedback loop promotes immune evasion and metastasis in bladder cancer.

Neutrophil extracellular traps-STC1 positive feedback loop promotes immune evasion and metastasis in bladder cancer.

Journal: Journal for immunotherapy of cancer

Published: November 03, 2025

Dissecting the role of KLF5: from tumor progression to immune interactions with emphasis on glioma and bladder cancer.

Dissecting the role of KLF5: from tumor progression to immune interactions with emphasis on glioma and bladder cancer.

Journal: Frontiers in immunology

Published: October 22, 2025

Disulfidptosis in cancer: from redox stress to therapeutic strategy.

Disulfidptosis in cancer: from redox stress to therapeutic strategy.

Journal: Cancer gene therapy

Published: September 28, 2025

DCLK1 drives malignant progression and chemoresistance of bladder cancer by deubiquitinating HDAC6.

DCLK1 drives malignant progression and chemoresistance of bladder cancer by deubiquitinating HDAC6.

Journal: Molecular cancer

Published: September 12, 2025

Medicine digital transformation: evidence from Chinese physicians on generative artificial intelligence implementation and challenges.

Medicine digital transformation: evidence from Chinese physicians on generative artificial intelligence implementation and challenges.

Journal: Journal of translational medicine

Published: September 07, 2025

Global, regional, and national bladder cancer burden from 1990 to 2021 and forecasts to 2050: a systematic analysis of the global disease burden study in 2021.

Global, regional, and national bladder cancer burden from 1990 to 2021 and forecasts to 2050: a systematic analysis of the global disease burden study in 2021.

Journal: BMC public health

Published: June 18, 2025

Temporal evolution of large language models (LLMs) in oncology.

Temporal evolution of large language models (LLMs) in oncology.

Journal: Journal of translational medicine

Published: June 10, 2025

Deciphering the role of ELAVL1: Insights from pan-cancer multiomics analyses with emphasis on nasopharyngeal carcinoma.

Deciphering the role of ELAVL1: Insights from pan-cancer multiomics analyses with emphasis on nasopharyngeal carcinoma.

Journal: Journal of translational internal medicine

Published: May 30, 2025

NSUN2-mediated m5C modification of SOCS3 mRNA modulates macrophage polarization in bladder cancer.

NSUN2-mediated m5C modification of SOCS3 mRNA modulates macrophage polarization in bladder cancer.

Journal: Cell death & disease

Published: May 28, 2025

Showing 1-12 of 71

Last Updated: 09/26/2026